Entities we value
Ambulatory surgery centers. Infusion and oncology centers. Imaging centers. Urgent care platforms. Home health and hospice agencies. Behavioral health providers. Dialysis centers. Laboratories. DME companies. Pharmacies. Hospital departments and service lines evaluated for joint venture or syndication.
Each carries its own economics — surgeon concentration in an ASC, drug margin and payer mix in an infusion center, certificate-of-need protection where it exists, reimbursement trajectory everywhere — and the valuation has to be built on those economics, not on a generic multiple.
Valuing a physician practice for a sale or partner transition? That work has its own page: medical practice valuation.